The impact of supplemental macular carotenoids in Alzheimer's disease: A randomized clinical trial

Journal of Alzheimer's Disease

Volumn 44, Issue 4, 2015, Pages 1157-1169

  Nolan, John M ^a   Loskutova, Ekaterina ^a   Howard, Alan ^b,c   Mulcahy, Riona ^d   Moran, Rachel ^a   Stack, Jim ^a   Bolger, Maggie ^d   Coen, Robert F ^e   Dennison, Jessica ^a   Akuffo, Kwadwo Owusu ^a   Owens, Niamh ^a   Power, Rebecca ^a   Thurnham, David ^f   Beatty, Stephen ^a  

^a South East Technological University   (Ireland)

^b Howard Foundation   (United Kingdom)

^c DOWNING COLLEGE   (United Kingdom)

^d WATERFORD REGIONAL HOSPITAL   (Ireland)

^e ST JAMES S HOSPITAL   (Ireland)

^f UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Age related macular degeneration; Alzheimer's disease; Cognitive function; Contrast sensitivity; Lutein; Mesozeaxanthin; Randomized clinical trial; Visual function; Zeaxanthin

Indexed keywords

MACUSHIELD; MESO ZEAXANTHIN; PLACEBO; SUNFLOWER OIL; UNCLASSIFIED DRUG; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN; ANTIOXIDANT; CAROTENOID;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; VERY ELDERLY; BLOOD; COGNITION DISORDERS; COMPLICATION; CONTRAST SENSITIVITY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LONGITUDINAL STUDY; MENTAL HEALTH; METABOLISM; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION DISORDERS; CONTRAST SENSITIVITY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUTEIN; MACULAR PIGMENT; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; VISUAL ACUITY; ZEAXANTHINS;

EID: 84941008715     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142265     Document Type: Article

References (54)

1. Nolan JM, Loskutova E, Howard AN, Moran R, Mulcahy R, Stack J, Bolger M, Dennison J, Akuffo KO, Owens N, Thurnham DI, Beatty S (2014) Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: An exploratory study. J Alzheimers Dis 42, 1191-1202.
2. Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: Retinal distribution and age study. Invest Ophthalmol Vis Sci 29, 843-849.
3. Wooten BR, Hammond BR, Land RI, Snodderly DM (1999) A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 40, 2481-2489.
4. Dennison JL, Stack J, Beatty S, Nolan JM (2013) Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance. Exp Eye Res 116, 190-198.
5. Hirsch J, Curcio CA (1989) The spatial resolution capacity of human foveal retina. Vision Res 29, 1095-1101.
6. Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25, 660-673.
7. Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38, 1802-1811.
8. Li B, Ahmed F, Bernstein PS (2010) Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys 504, 56-60.
9. Chew EY, Clemons TE, SanGiovanni JP, Danis RP, Ferris FL III, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agron E, Toth CA, Bernstein PS, Sperduto RD (2013) Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol 132, 142-149.
10. Loughman J, Akkali MC, Beatty S, Scanlon G, Davison PA, O'Dwyer V, Cantwell T, Major P, Stack J, Nolan JM (2010) The relationship between macular pigment and visual performance. Vision Res 50, 1249-1256.
11. Loughman J, Nolan JM, Howard AN, Connolly E, Meagher K, Beatty S (2012) The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci 53, 7871-7880.
12. Sabour-Pickett S, Beatty S, Connolly E, Loughman J, Stack J, Howard A, Klein R, Klein BE, Meuer SM, Myers CE, Akuffo KO, Nolan JM (2014) Supplementation with three different macular carotenoid formulations in patients with early agerelated macular degeneration. Retina 34, 1757-1766.
13. Huang YM, Yan SF, Ma L, Zou ZY, Xu XR, Dou HL, Lin XM (2013) Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration. Nutrition 29, 387-392.
14. Murray IJ, Makridaki M, van der Veen RL, Carden D, Parry NR, Berendschot TT (2013) Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: The CLEAR study. Invest Ophthalmol Vis Sci 54, 1781-1788.
15. Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhofer G, Schmidt-Erfurth U, Schmetterer L (2011) Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52, 8174-8178.
16. Wooten BR, Hammond BR (2002) Macular pigment: Influences on visual acuity and visibility. Prog Retin Eye Res 21, 225-240.
17. Craft NE, Haitema TB, Garnett KM, Fitch KA, Dorey CK (2004) Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 8, 156-162.
18. Vishwanathan R, Neuringer M, Snodderly DM, Schalch W, Johnson EJ (2013) Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr Neurosci 16, 21-29.
19. Johnson EJ, Vishwanathan R, Johnson MA, Hausman DB, Davey A, Scott TM, Green RC, Miller LS, Gearing M, Woodard J, Nelson PT, Chung HY, Schalch W, Wittwer J, Poon LW (2013) Relationship between serum and brain carotenoids, alpha-tocopherol, and retinol concentrations and cognitive performance in the oldest old from the Georgia Centenarian Study. J Aging Res 2013, 951786.
20. Vishwanathan R, Iannaccone A, Scott TM, Kritchevsky SB, Jennings BJ, Carboni G, Forma G, Satterfield S, Harris T, Johnson KC, Schalch W, Renzi LM, Rosano C, Johnson EJ (2014) Macular pigment optical density is related to cognitive function in older people. Age Ageing 43, 271-275.
21. Renzi LM, Dengler MJ, Puente A, Miller LS, HammondBRJr (2014) Relationshipsbetweenmacularpigmentoptical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiol Aging 35, 1695-1699.
22. Feeney J, Finucane C, Savva GM, Cronin H, Beatty S, Nolan JM, Kenny RA (2013) Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiol Aging 34, 2449-2456.
23. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM (2008) Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 11, 75-83.
24. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152-1156.
25. Teunissen CE, van Boxtel MP, Bosma H, Bosmans E, Delanghe J, De BC, Wauters A, Maes M, Jolles J, Steinbusch HW, de Vente J (2003) Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 134, 142-150.
26. Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G, Thal LJ, Sano M, Refolo LM (2002) Cholesterol, oxidative stress, and Alzheimer's disease: Expanding the horizons of pathogenesis. Free Radic Biol Med 33, 173-181.
27. Wyss-Coray T (2006) Inflammation in Alzheimer disease: Driving force, bystander or beneficial response?. Nat Med 12, 1005-1015.
28. Ciccone MM, Cortese F, Gesualdo M, Carbonara S, Zito A, Ricci G, De Pascalis F, Scicchitano P, Riccioni G (2013) Dietary intake of carotenoids and their antioxidant and antiinflammatory effects in cardiovascular care. Mediators Inflam 2013, 782137.
29. Kijlstra A, Tian Y, Kelly ER, Berendschot TT (2012) Lutein: More than just a filter for blue light. Prog Retin Eye Res 31, 303-315.
30. Johnson EJ (2012) A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am J Clin Nutr 96, 1161S-1165S.
31. Stahl W, Sies H (2001) Effects of carotenoids and retinoids on gap junctional communication. Biofactors 15, 95-98.
32. StahlW, Nicolai S, Briviba K, Hanusch M, Broszeit G, Peters M, Martin HD, Sies H (1997) Biological activities of natural and synthetic carotenoids: Induction of gap junctional communication and singlet oxygen quenching. Carcinogenesis 18, 89-92.
33. Strauss E, SchermanEMS, SpreenO(2006)ACompendium of Neuropsychological Tests. Administration, Norms and Commentary, Oxford University Press; New York.
34. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB): A factor analytic study of a large sample of normal elderly volunteers. Dementia 5, 266-281.
35. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111(Pt 3), 695-718.
36. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28, 1021-1034.
37. Charalampidou S, Nolan J, Loughman J, Stack J, Higgins G, Cassidy L, Beatty S (2011) Psychophysical impact and optical and morphological characteristics of symptomatic non-advanced cataract. Eye (Lond) 25, 1147-1154.
38. Nolan JM, Loughman J, Akkali MC, Stack J, Scanlon G, Davison P, Beatty S (2011) The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vision Res 51, 459-469.
39. Akuffo KO, Beatty S, Stack J, Dennison J, O'Regan S, Meagher KA, Peto T, Nolan J (2014) Central Retinal Enrichment Supplementation Trials (CREST): Design and methodology of the CREST randomized controlled trials. Ophthalmic Epidemiol 21, 111-123.
40. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis DM, de Jong PT, Klaver CC, Klein BE, Klein R, et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39, 367-374.
41. Neelam K, Muldrew A, Hogg R, Stack J, Chakravarthy U, Beatty S (2009) Grading of age-related maculopathy: Slitlamp biomicroscopy versus an accredited grading center. Retina 29, 192-198.
42. Delori FC (2004) Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys 430, 156-162.
43. Perry A, Rasmussen H, Johnson EJ (2009) Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and egg products. J Food Compost Anal 22, 9-15.
44. Thurnham DI, Tremel A, Howard AN (2008) A supplementation study in human subjects with a combination of meso-zeaxanthin, (3R, 3'R)-zeaxanthin and (3R, 3'R, 6'R)-lutein. Br J Nutr 100, 1307-1314.
45. Hintze J (2008) PASS 2008. NCSS LLC, http://www. ncss.com
46. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates, Hillsdale, New Jersey.
47. Morley JE (2010) Nutrition and the brain. Clin Geriatr Med 26, 89-98.
48. Salerno-Kennedy R, Cashman KD (2007) The relationship between nutrient intake and cognitive performance in people at risk of dementia. Ir J Med Sci 176, 193-198.
49. MiW, vanWijk N, CansevM, SijbenJW, Kamphuis PJ (2013) Nutritional approaches in the risk reduction and management of Alzheimer's disease. Nutrition 29, 1080-1089.
50. Min JY, Min KB (2014) Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer's disease mortality in older adults. Dement Geriatr Cogn Disord 37, 246-256.
51. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24, 915-919.
52. Meagher KA, Thurnham DI, Beatty S, Howard AN, Connolly E, Cummins W, Nolan JM (2013) Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. Br J Nutr 110, 289-300.
53. Nolan JM, Akkali MC, Loughman J, Howard AN, Beatty S (2012) Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Exp Eye Res 101, 9-15.
54. Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR (2013) Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology 120, 600-606.